184 related articles for article (PubMed ID: 22365772)
61. Lentiviral gene therapy for X-linked chronic granulomatous disease.
Kohn DB; Booth C; Kang EM; Pai SY; Shaw KL; Santilli G; Armant M; Buckland KF; Choi U; De Ravin SS; Dorsey MJ; Kuo CY; Leon-Rico D; Rivat C; Izotova N; Gilmour K; Snell K; Dip JX; Darwish J; Morris EC; Terrazas D; Wang LD; Bauser CA; Paprotka T; Kuhns DB; Gregg J; Raymond HE; Everett JK; Honnet G; Biasco L; Newburger PE; Bushman FD; Grez M; Gaspar HB; Williams DA; Malech HL; Galy A; Thrasher AJ;
Nat Med; 2020 Feb; 26(2):200-206. PubMed ID: 31988463
[TBL] [Abstract][Full Text] [Related]
62. An AAVS1-targeted minigene platform for correction of iPSCs from all five types of chronic granulomatous disease.
Merling RK; Sweeney CL; Chu J; Bodansky A; Choi U; Priel DL; Kuhns DB; Wang H; Vasilevsky S; De Ravin SS; Winkler T; Dunbar CE; Zou J; Zarember KA; Gallin JI; Holland SM; Malech HL
Mol Ther; 2015 Jan; 23(1):147-57. PubMed ID: 25288370
[TBL] [Abstract][Full Text] [Related]
63. Allogeneic Hematopoietic Cell Transplantation for Chronic Granulomatous Disease: Controversies and State of the Art.
Connelly JA; Marsh R; Parikh S; Talano JA
J Pediatric Infect Dis Soc; 2018 May; 7(suppl_1):S31-S39. PubMed ID: 29746680
[TBL] [Abstract][Full Text] [Related]
64. Hyperinflammation in patients with chronic granulomatous disease leads to impairment of hematopoietic stem cell functions.
Weisser M; Demel UM; Stein S; Chen-Wichmann L; Touzot F; Santilli G; Sujer S; Brendel C; Siler U; Cavazzana M; Thrasher AJ; Reichenbach J; Essers MAG; Schwäble J; Grez M
J Allergy Clin Immunol; 2016 Jul; 138(1):219-228.e9. PubMed ID: 26853280
[TBL] [Abstract][Full Text] [Related]
65. Recent advances in chronic granulomatous disease.
Goldblatt D
J Infect; 2014 Nov; 69 Suppl 1():S32-5. PubMed ID: 25264161
[TBL] [Abstract][Full Text] [Related]
66. Reconstitution of NADPH oxidase activity in human X-linked chronic granulomatous disease myeloid cells after stable gene transfer using a recombinant adeno-associated virus 2 vector.
Li LL; Dinauer
Blood Cells Mol Dis; 1998 Dec; 24(4):522-38. PubMed ID: 9880243
[TBL] [Abstract][Full Text] [Related]
67. Recent Advances in Gene Therapy and Modeling of Chronic Granulomatous Disease.
Jafarian A; Shokri G; Shokrollahi Barough M; Moin M; Pourpak Z; Soleimani M
Iran J Allergy Asthma Immunol; 2019 Apr; 18(2):131-142. PubMed ID: 31066249
[TBL] [Abstract][Full Text] [Related]
68. Lentiviral Vector Gene Therapy Protects XCGD Mice From Acute Staphylococcus aureus Pneumonia and Inflammatory Response.
Farinelli G; Jofra Hernandez R; Rossi A; Ranucci S; Sanvito F; Migliavacca M; Brombin C; Pramov A; Di Serio C; Bovolenta C; Gentner B; Bragonzi A; Aiuti A
Mol Ther; 2016 Oct; 24(10):1873-1880. PubMed ID: 27456061
[TBL] [Abstract][Full Text] [Related]
69. Advances in the treatment of Chronic Granulomatous Disease by gene therapy.
Ott MG; Seger R; Stein S; Siler U; Hoelzer D; Grez M
Curr Gene Ther; 2007 Jun; 7(3):155-61. PubMed ID: 17584034
[TBL] [Abstract][Full Text] [Related]
70. Chronic granulomatous disease - conventional treatment vs. hematopoietic stem cell transplantation: an update.
Åhlin A; Fasth A
Curr Opin Hematol; 2015 Jan; 22(1):41-5. PubMed ID: 25394312
[TBL] [Abstract][Full Text] [Related]
71. Gene therapy for chronic granulomatous disease.
Ryser MF; Roesler J; Gentsch M; Brenner S
Expert Opin Biol Ther; 2007 Dec; 7(12):1799-809. PubMed ID: 18034646
[TBL] [Abstract][Full Text] [Related]
72. Advances in the diagnosis and treatment of chronic granulomatous disease.
Seger RA
Curr Opin Hematol; 2011 Jan; 18(1):36-41. PubMed ID: 21076296
[TBL] [Abstract][Full Text] [Related]
73. Haploidentical hematopoietic stem cell transplantation for a case with X-linked chronic granulomatous disease.
Zhou L; Dong LJ; Gao ZY; Yu XJ; Lu DP
Pediatr Transplant; 2017 Feb; 21(1):. PubMed ID: 27885760
[TBL] [Abstract][Full Text] [Related]
74. TALEN-mediated functional correction of X-linked chronic granulomatous disease in patient-derived induced pluripotent stem cells.
Dreyer AK; Hoffmann D; Lachmann N; Ackermann M; Steinemann D; Timm B; Siler U; Reichenbach J; Grez M; Moritz T; Schambach A; Cathomen T
Biomaterials; 2015 Nov; 69():191-200. PubMed ID: 26295532
[TBL] [Abstract][Full Text] [Related]
75. Chronic granulomatous disease: lessons from a rare disorder.
Segal BH; Veys P; Malech H; Cowan MJ
Biol Blood Marrow Transplant; 2011 Jan; 17(1 Suppl):S123-31. PubMed ID: 21195301
[TBL] [Abstract][Full Text] [Related]
76. Functional reconstitution of the NADPH-oxidase by adeno-associated virus gene transfer.
Thrasher AJ; de Alwis M; Casimir CM; Kinnon C; Page K; Lebkowski J; Segal AW; Levinsky RJ
Blood; 1995 Jul; 86(2):761-5. PubMed ID: 7606005
[TBL] [Abstract][Full Text] [Related]
77. Retroviral gene therapy for X-linked chronic granulomatous disease: results from phase I/II trial.
Kang HJ; Bartholomae CC; Paruzynski A; Arens A; Kim S; Yu SS; Hong Y; Joo CW; Yoon NK; Rhim JW; Kim JG; Von Kalle C; Schmidt M; Kim S; Ahn HS
Mol Ther; 2011 Nov; 19(11):2092-101. PubMed ID: 21878903
[TBL] [Abstract][Full Text] [Related]
78. Successful Combination of Sequential Gene Therapy and Rescue Allo-HSCT in Two Children with X-CGD - Importance of Timing.
Siler U; Paruzynski A; Holtgreve-Grez H; Kuzmenko E; Koehl U; Renner ED; Alhan C; de Loosdrecht AA; Schwäble J; Pfluger T; Tchinda J; Schmugge M; Jauch A; Naundorf S; Kühlcke K; Notheis G; Güngor T; Kalle CV; Schmidt M; Grez M; Seger R; Reichenbach J
Curr Gene Ther; 2015; 15(4):416-27. PubMed ID: 25981636
[TBL] [Abstract][Full Text] [Related]
79. Advances in treatment for chronic granulomatous disease.
Kang EM; Malech HL
Immunol Res; 2009; 43(1-3):77-84. PubMed ID: 18806936
[TBL] [Abstract][Full Text] [Related]
80. Gene therapy of chronic granulomatous disease: the engraftment dilemma.
Grez M; Reichenbach J; Schwäble J; Seger R; Dinauer MC; Thrasher AJ
Mol Ther; 2011 Jan; 19(1):28-35. PubMed ID: 21045810
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
